Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Immunization approaches a… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kontaktformulär








 


OBS! Vill du ha svar, ange e-post eller telefonnummer!




Immunization approaches and molecular signatures for mucosal immunity to primary and recurrent genital herpes

Doktorsavhandling
Författare Josefine Persson
Datum för examination 2015-06-11
ISBN 978-91-628-9438-2
Publiceringsår 2015
Publicerad vid Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi
Språk en
Länkar hdl.handle.net/2077/38383
Ämnesord Immunologi
Ämneskategorier Mikrobiologi inom det medicinska området

Sammanfattning

Genital herpes is most commonly caused by herpes simplex virus type 2 (HSV-2), and is a prevalent sexually transmitted infection worldwide. Despite numerous efforts, there is currently no licensed vaccine against the disease. This thesis evaluates the potential of different immunization strategies to engender protective immunity to genital herpes, using animal models of HSV-2 infection. Studying early molecular and cellular signatures of vaginal immunity to genital herpes represents the secondary objective of this thesis. A well-established mouse model of genital herpes was used to investigate immunogenicity and protection against primary genital HSV-2 infection. A guinea pig model, which displays a HSV-2 infection that closely resembles the pathogenesis and symptoms of the disease in humans, was employed for studying the impact of immunization on the establishment of latency and recurrent genital herpes. Surface plasmon resonance technology was used to study the avidity and neutralizing epitope profile of IgG antibodies raised towards HSV-2 envelope glycoprotein D (gD) by immunization. Whole-genome microarray analysis combined with systems biology, protein array analysis and flow cytometry were used to identify early immune events in the murine vagina after delivery of a live attenuated HSV-2 strain, known as the gold standard for induction of protective immunity in mice. Main results presented in this thesis include: I) Nasal and skin immunization with recombinant HSV-2 gD antigen in combination with the clinically tested adjuvant IC31® was highly efficient for induction of specific B and T cell responses and protection against primary genital herpes in mice; II) Nasal immunization elicited a high avidity, HSV-2 neutralizing IgG antibody response as well as protective immunity to both primary and recurrent genital herpes infection, with partial reduction of viral latency, in guinea pigs; and III) Identification of local inflammatory imprints connected to immune cell recruitment after vaginal immunization with live attenuated HSV-2 in mice. The results presented in this thesis provide evidence on the potential of nasal and dermal immunization for induction of protective immunity to genital herpes as well as early molecular and cellular signatures of the protective immune response in the vaginal mucosa. These results may inform rational development of a vaccine to counter genital herpes infection in humans.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://www.gu.se/forskning/publikation/?feedbackForm=true&returnAddress=http%3A%2F%2Fwww.gu.se%2Fforskning%2Fpublikation%2F%3Fprint%3Dtrue%26publicationId%3D217640&recipientName=Webbredaktion&encodedEmail=YW5uaWthLndhbGxAZ3Uuc2U&publicationId=217640
Utskriftsdatum: 2020-04-02